- Home
- Medical news & Guidelines
- Anesthesiology
- Cardiology and CTVS
- Critical Care
- Dentistry
- Dermatology
- Diabetes and Endocrinology
- ENT
- Gastroenterology
- Medicine
- Nephrology
- Neurology
- Obstretics-Gynaecology
- Oncology
- Ophthalmology
- Orthopaedics
- Pediatrics-Neonatology
- Psychiatry
- Pulmonology
- Radiology
- Surgery
- Urology
- Laboratory Medicine
- Diet
- Nursing
- Paramedical
- Physiotherapy
- Health news
- Fact Check
- Bone Health Fact Check
- Brain Health Fact Check
- Cancer Related Fact Check
- Child Care Fact Check
- Dental and oral health fact check
- Diabetes and metabolic health fact check
- Diet and Nutrition Fact Check
- Eye and ENT Care Fact Check
- Fitness fact check
- Gut health fact check
- Heart health fact check
- Kidney health fact check
- Medical education fact check
- Men's health fact check
- Respiratory fact check
- Skin and hair care fact check
- Vaccine and Immunization fact check
- Women's health fact check
- AYUSH
- State News
- Andaman and Nicobar Islands
- Andhra Pradesh
- Arunachal Pradesh
- Assam
- Bihar
- Chandigarh
- Chattisgarh
- Dadra and Nagar Haveli
- Daman and Diu
- Delhi
- Goa
- Gujarat
- Haryana
- Himachal Pradesh
- Jammu & Kashmir
- Jharkhand
- Karnataka
- Kerala
- Ladakh
- Lakshadweep
- Madhya Pradesh
- Maharashtra
- Manipur
- Meghalaya
- Mizoram
- Nagaland
- Odisha
- Puducherry
- Punjab
- Rajasthan
- Sikkim
- Tamil Nadu
- Telangana
- Tripura
- Uttar Pradesh
- Uttrakhand
- West Bengal
- Medical Education
- Industry
Zinc supplementation could prevent type 2 diabetes in obese patients
Taiwan: Zinc supplementation is beneficial for blood sugar control in patients with overweight/obesity, with an especially significant reduction in fasting glucose (FG), a recent meta-analysis has suggested.
The findings, published in Obesity Research & Clinical Practice, suggest that zinc supplementation could be a viable adjunct therapy to reduce the risk of diabetes development in obese/overweight individuals.
Over 40% of the global population is reported to be affected by obesity and overweight, and their growing prevalence is of concern. Some studies have shown that overweight and obese people have a higher risk of type 2 diabetes (T2D) incidence than normal-weight individuals.
Several studies have shown that zinc plays a critical role in the pathophysiology of glycemic metabolism and affects insulin homeostasis. Still, the efficacy of zinc supplementation in blood sugar control among overweight and obese people remains unknown. Hao-Yu Yang, Kaohsiung Veterans General Hospital, Kaohsiung City, Taiwan, and colleagues aimed to evaluate the effectiveness of zinc supplementation for blood sugar control among overweight and obese individuals in a meta-analysis. They hypothesized that zinc supplementation would improve the blood sugar parameters of this population.
For this purpose, the researchers searched the online databases from inception until May 2022 for RCTs (randomized controlled trials) investigating the effects of zinc supplementation among overweight/obese people without language restriction. It is a random-effect meta-analysis that analyzed the effect of zinc supplementation on fasting glucose (primary outcome) and other variables, including homeostasis model assessment-insulin resistance index (HOMA-IR), fasting insulin (FI), 2-hour postprandial glucose (2 h- PG), high-sensitivity C-reactive protein (hs-CRP), and glycated haemoglobin (HbA1c).
The study led to the following findings:
- Analysis of 12 eligible RCTs comprising 651 overweight/obese participants showed that zinc supplementation significantly improves FG (weighted mean difference [WMD]: −8.57 mg/dL), HOMA-IR (WMD: −0.54), HbA1c (WMD: −0.25%), and two h-PG (WMD: −18.42 mg/dL) compared to those in the control group.
- After conducting subgroup analyses, the authors found that the primary outcome, fasting glucose, showed more significant results in the subgroups with Asia, Zinc supplementation alone, higher dose (≥30 mg) and patients with diabetes.
"Our meta-analysis revealed that zinc supplementation benefits insulin resistance and blood sugar control in overweight/obese populations, significantly reducing two h-PG, HbA1c, HOMA-IR, and FG," the researchers wrote.
Based on the findings, they suggested that zinc supplementation could be a viable adjunct therapy to reduce the risk of diabetes in this population.
"Contrary to prior meta-analyses, subgroup analyses revealed that zinc supplementation alone and at higher dosages resulted in reduced FG and HOMA-IR," they wrote. The team indicate the need for further large RCTs to strengthen the evidence base for optimal zinc dosage.
Reference:
Yang, H., Hung, K., Chuang, M., Chang, R., Chen, R., Wang, F., Wu, J., & Chen, J. (2023). Effect of zinc supplementation on blood sugar control in the overweight and obese population: A systematic review and meta-analysis of randomized controlled trials. Obesity Research & Clinical Practice. https://doi.org/10.1016/j.orcp.2023.06.003
MSc. Biotechnology
Medha Baranwal joined Medical Dialogues as an Editor in 2018 for Speciality Medical Dialogues. She covers several medical specialties including Cardiac Sciences, Dentistry, Diabetes and Endo, Diagnostics, ENT, Gastroenterology, Neurosciences, and Radiology. She has completed her Bachelors in Biomedical Sciences from DU and then pursued Masters in Biotechnology from Amity University. She has a working experience of 5 years in the field of medical research writing, scientific writing, content writing, and content management. She can be contacted at  editorial@medicaldialogues.in. Contact no. 011-43720751
Dr Kamal Kant Kohli-MBBS, DTCD- a chest specialist with more than 30 years of practice and a flair for writing clinical articles, Dr Kamal Kant Kohli joined Medical Dialogues as a Chief Editor of Medical News. Besides writing articles, as an editor, he proofreads and verifies all the medical content published on Medical Dialogues including those coming from journals, studies,medical conferences,guidelines etc. Email: drkohli@medicaldialogues.in. Contact no. 011-43720751